Efficacy and Safety of Single-session Endoscopic Stone Extraction
NCT ID: NCT06327126
Last Updated: 2024-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
563 participants
OBSERVATIONAL
2024-01-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Safety of Single-session Endoscopic Stone Extraction
NCT06349954
Chinese Registry Study on Treatment of Cholecysto-Choledocholithiasis
NCT02554097
Optimizing the Evaluation and Management of Patients With Suspected Choledocholithiasis
NCT05141916
Safety and Efficacy Study of Transumbilical Laparoendoscopic Single Site Cholecystectomy
NCT01383031
Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease
NCT04308993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a retrospective analysis, approximately 600 patients with acute cholangitis accompanied with choledocholithiasis, who treated with single-session or two-session endoscopic stone extraction at Beijing friendship hospital were studied. The investigators assessed the outcomes of single-stage and two-stage endoscopic stone extraction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
two-session treatment group
two-session ERCP
two-session ERCP
early endoscopic drainage followed by endoscopic stone extraction
single-session treatment group
single-session ERCP
single-session ERCP
directly endoscopic stone extraction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
two-session ERCP
early endoscopic drainage followed by endoscopic stone extraction
single-session ERCP
directly endoscopic stone extraction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients met the Tokyo Guidelines 2018 (TG18) diagnosis of acute cholangitis
3. Imaging examination confirmed the presence of choledocholithiasis
4. Patients received endoscopic single-session stone extraction or two-session treatment involving stone removal after drainage
Exclusion Criteria
2. Changes in the anatomical structure of the stomach or duodenum
3. Patients complicated with severe acute pancreatitis
4. Patients who underwent endoscopic intervention before admission
5. Patients received percutaneous transhepatic cholangio drainage (PTCD) or other invasive interventions besides endoscopic treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fujing Lv, M.D.
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BFHHZS20240001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.